This suggests that passive immunization with tau antibodies is really a feasible therapeutic concentrate on and which the CSF volume of p-tau262/356 or of the microtubule binding area (MTBD) can function a handy biomarker of tau pathology to watch tau therapeutics in medical trials. To Jubao Duan